010-58156160-822
CNTo facilitate the internationalization of Chinese innovative brands by promoting and implementing the national Innovation Driven Development Strategy, enhancing the core competitiveness of innovative technology and advancing the process of strengthening the nation by technology and pharmaceutical development, China Pharmaceutical Innovation and Research Development Association (PhIRDA) and Suzhou Industrial Park have reached a consensus on co-hosting the “Dushu Lake Prize” Selection Activities of China Pharmaceutical Innovation Brand (herein after referred to as the Selection Activities) in 2018. Both sides will join hands to make the Selection Activities a fair, just, and open session.
The Selection Activities adopts the mechanism of expert recommendation. Any applications from enterprises shall not be taken into consideration. The selection will follow the peer review system of international innovation standards and scientific awards to set the awards for the most innovative drugs, figures (Chinese scientists) and financial institutions.
 Sang Guowei
Sang Guowei
Vice Chairman of the Standing Committee of 11th National People’s Congress, Academician of Chinese Academy of Engineering (CAE)
 Kaixian  Chen
Kaixian  Chen
Academician of Chinese Academy of Sciences (CAS), Researcher, Director of Academic Degree Committee of Shanghai Institute of Materia Medica (SIMM), CAS
 Jiang Jiandong
Jiang Jiandong
Director of Institute of Materia Medica (IMM), Chinese Academy of Medical Sciences (CAMS)
 Zhang Boli
Zhang Boli
Academician of CAE, Former President of China Academy of Chinese Medical Sciences, President of Tianjin University of Traditional Chinese Medicine
 Jiang Hualiang
Jiang Hualiang
Academician of CAS, Researcher of SIMM, CAS
 Zhao Kai
Zhao Kai
Academician of CAE, Researcher of National Vaccine and Serum Institute
 Ding Jian
Ding Jian
Academician of CAE, Academician of the World Academy of Sciences
 Wang Guangji
Wang Guangji
Academician of CAE, Chairman of the Academic Committee & Director of Key Laboratory,China Pharmaceutical University
 Ge Junbo
Ge Junbo
Academician of CAS, Dean of Institutes of Biomedical Sciences, Fudan University, Director of Cardiology Department of Zhongshan Hospital, Fudan University
 Wei Yuquan
Wei Yuquan
Academician of CAS, Professor of National Key Laboratory of Biotherapy, Sichuan University
 Li Lin
Li Lin
Academician of CAS, President of Shanghai Institutes for Biological Sciences, CAS 
 Chen Jianfeng
Chen Jianfeng
Academician of CAE, Vice President of Beijing University of Chemical Technology
 Yue Jianmin
Yue Jianmin
Academician of CAS, Researcher of SIMM, CAS
 Li Zhaoshen
Li Zhaoshen
Academician of CAE, Director of Department of Gastroenterology of Changhai Hospital of Shanghai
 Ye Yuru
Ye Yuru
Academician of CAS, Foreign Academician of National Academy of Sciences, United States
 Wang Hongyang
Wang Hongyang
Academician of CAE, Director of The National Center for Science in Hepatocellular Carcinoma
 Yu Jinming
Yu Jinming
Academician of CAE, Honorary President/Principal of Shandong First Medical University & Shandong Academy of Medical Sciences
 Ning Guang
Ning Guang
Academician of CAE, Vice President of Ruijin Hospital, Shanghai Jiaotong University
 Wang Junzhi
Wang Junzhi
Academician of CAE, Chief Expert for Biological Product Testing in National Institutes for Food and Drug Control (NIFDC)
 Lai Maode
Lai Maode
President of China Pharmaceutical University
 Wu Chunfu
Wu Chunfu
Professor of Shenyang Pharmaceutical University
 Wu Xiaoming
Wu Xiaoming
Professor & Former President of China Pharmaceutical University
 Chen Xiaoguang
Chen Xiaoguang
Director of Department of Pharmacology of IMM, CAMS
 Ji Jiafu
Ji Jiafu
President of Beijing Cancer Hospital
 Wang Yongjun
Wang Yongjun
Executive Deputy Dean of Beijing Tiantan Hospital, Capital Medical University
 Shi Yuankai
Shi Yuankai
Deputy Director of National Cancer Center, Vice President of Cancer Hospital, CAMS
 Zhang Shuyang
Zhang Shuyang
President of Peking Union Medical College Hospital, vice president of China Alliance for Rare Diseases
 Wu Yilong
Wu Yilong
Tenured Professor & Director of Guangdong General Hospital (GGH)
 Zhou Zhiguang
Zhou Zhiguang
President of the Second Xiangya Hospital of Central South University
 Qin Shukui
Qin Shukui
Director of Cancer Center of General Hospital of Eastern Theater Command
 Huo Yong
Huo Yong
Director of Department of Cardiology and Heart Center, Peking University First Hospital
 Ma Jun
Ma Jun
Executive Vice President of Sun Yat-Sen University Cancer Center
 He Ruyi
He Ruyi
Chief Scientist at SDIC, Former Chief Scientist at Center for Drug Evaluation of NMPA
 Hou Jian
Hou Jian
Director of Department of Hematology of Renji Hospital of Shanghai Jiaotong University School of Medicine
 Li Wenbin
Li Wenbin
Director of Department of Neuro-Oncology of Beijing Tiantan Hospital, Capital Medical University
 Li Jia
Li Jia
Director of SIMM, CAS, Director of State Key Laboratory of Drug Research
 Liang Jun
Liang Jun
Vice President, Director of Cancer Center of Peking University International Hospital
 Ma Jun
Ma Jun
Director of Harbin Institute of Hematology
 Hu Yi
Hu Yi
Director of Oncology Department, Chinese PLA General Hospital
 Wang Weiqing
Wang Weiqing
Director of the Department of Endocrine and Metabolism of Ruijin Hospital
 Shi Jin
Shi Jin
DirectorDirector of Neurology Department of Air Force General Hospital, PLA
 Zhang Shucai
Zhang Shucai
ChiefDirector of the Oncology Medicine Department of Beijing Chest Hospital, Capital Medical University
 Dong Qiang
Dong Qiang
Director of Department of Neurology of Huashan Hospital
 Linghu Enqiang
Linghu Enqiang
Director of Department of Gastroenterology, Chinese PLA General Hospital
 Li Jin
Li Jin
Director of Department of Oncology of Shanghai East Hospital, Tongji University
 Zhong Wu
Zhong Wu
Director of National Engineering Research Center for the Emergency Drug
 Zhu Xiaoxin
Zhu Xiaoxin
Researcher of Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
 Xuan Jianwei
Xuan Jianwei
Director of Medicine Economic Research Institute of School of Pharmaceutical Sciences, Sun Yat-Sen University
 Shen Xinliang
Shen Xinliang
Vice Chairman of the Committee of Genetic Engineering Drugs
 Huang Jiaoti
Huang Jiaoti
Tenure Professor and Department Head of Duke University Medical Center
 Song Wenru
Song Wenru
Co-founder, President and Head of R&D of Kira Pharmaceuticals
 Ren Jin
Ren Jin
Director of Center for Drug Safety Evaluation and Research of SIMM, CAS
 Wang Xinghe
Wang Xinghe
Director of New Drug Clinical Trial Center of Beijing Shijitan Hospital, Capital Medical University
 Cui Yimin
Cui Yimin
Director of Clinical Trial Center, Peking University First Hospital
 Hu Xin
Hu Xin
Director of Department of Pharmacy, Beijing Hospital
 Wang Xiaoling
Wang Xiaoling
Director of Department of Pharmacy, Beijing Childrens Hospital, Capital Medical University
 Li Kexin
Li Kexin
Director of Beijing Hospital Clinical Trial Research Center (BJH-CTC)
 Song Ruilin
Song Ruilin
Chairman of China Pharmaceutical Innovation and Research Development Association (PhIRDA)
 Addressed by Song Ruilin, Chairman of PhIRDA
        Addressed by Song Ruilin, Chairman of PhIRDA
    
 Addressed by Wu Qingwen, Member of the Standing Committee of CPC Suzhou Committee, Secretary of SIP Working Committee
        Addressed by Wu Qingwen, Member of the Standing Committee of CPC Suzhou Committee, Secretary of SIP Working Committee
    
 Winner of Award for Medical Innovation Lifetime Achievement
        Winner of Award for Medical Innovation Lifetime Achievement
    
 Winner of Most Innovative Figure of Drug R&D Award (International Areas)
        Winner of Most Innovative Figure of Drug R&D Award (International Areas)
    
 Winner of Most Innovative Figure of Drug R&D Award
        Winner of Most Innovative Figure of Drug R&D Award
    
 Winner of Clinical Trial Protocol Design Award
        Winner of Clinical Trial Protocol Design Award